Fact Check: AI Did Not Control the Covid-19 Pandemic
Artificial Intelligence served as a support tool for health specialists during the Covid-19 pandemic rather than an autonomous controller, according to a scientific paper published in 2025. While AI helped analyze data and accelerate vaccine development, final decisions regarding public health measures were made by governments, the World Health Organization (WHO), and the European Union.
How was AI used during the pandemic?
Specialists utilized AI programs to respond to infection foci and analyze massive volumes of data in record time, according to the 2025 study. These tools allowed researchers to develop vaccines more quickly and use forecasting models to anticipate virus transmission.

The technology also helped medical staff monitor the evolution of the disease in hospitalized patients. This data supported the more efficient allocation of resources within hospitals, the study notes.
Who actually controlled the pandemic response?
Governments, the European Union, and the WHO made the final decisions on measures to prevent and limit the spread of Sars-CoV-2. AI acted as an instrument that provided results based on data supplied by humans, the researchers explain.
IBM defines AI as technology that allows computers to imitate human processes—such as learning, understanding, and problem-solving—at a capacity exceeding that of humans. However, in the medical context of the pandemic, these systems operated under the direct supervision of specialists.
What were the ethical risks and regulations?
The 2025 paper highlights isolated cases where AI-driven mobile monitoring applications raised concerns about personal data safety, specifically in Singapore and India.
No international legislation existed to guide or limit the use of AI in medicine during the height of the pandemic. The European Union later addressed this gap by adopting the AI Act in August 2024, followed by a code of good practices in 2025.
What may happen next with medical AI?
Future health crises could see a more regulated integration of AI, as the 2025 code of good practices may provide a blueprint for other regions. The continued use of AI in the EU for disease detection suggests that these tools are likely to become standard components of public health infrastructure.
The adoption of stricter data privacy laws could potentially reduce the types of safety concerns seen in earlier monitoring apps used in Asia.
Frequently Asked Questions
Did AI coordinate the “Covid operation” independently?
No. According to the 2025 scientific paper, AI was a tool used by scientists and epidemiologists; final decisions were made by governments, the WHO, and the EU.
What were the primary benefits of using AI during the pandemic?
AI helped specialists analyze large datasets quickly, respond to infection foci, accelerate vaccine development, and predict virus transmission and patient evolution.
Were there any negative impacts associated with AI usage?
The source mentions isolated cases in India and Singapore where AI monitoring apps raised suspicions regarding the safety of personal data.
Do you believe that strict regulation of AI in medicine should be established before a health crisis occurs?